ImmuONE awarded Innovate UK funding

ImmuONE™ won their bid in a competitive funding round from Innovate UK to commercialise their first product in the pipeline, ImmuLUNG™. The technology provides an accurate physiological and functional representation of the human alveolus, providing a reliable platform to assess the safety of inhaled compounds.